The market performance of Candel Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $14.60 on 12/11/24, while the lowest value for the same duration was $1.45 on 03/27/24.
52-week price history of CADL Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Candel Therapeutics Inc’s current trading price is -48.63% away from its 52-week high, while its distance from the 52-week low is 417.24%. The stock’s price range during the 52-week period has remained between $1.45 and $14.60. In the Healthcare sector, the company’s shares saw a trading volume of around 0.96 million for the day, which was evidently lower than the average daily volume of 1.27 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Candel Therapeutics Inc (CADL) has experienced a quarterly decline of -14.29% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 354.27M and boasts a workforce of 38 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.23, with a change in price of +2.05. Similarly, Candel Therapeutics Inc recorded 2,796,803 in trading volume during the last 100 days, posting a change of +37.49%.
Examining CADL’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CADL stands at 0.20. Similarly, the long-term debt-to-equity ratio is also 0.05.
CADL Stock Stochastic Average
Candel Therapeutics Inc’s raw stochastic average for the past 50 days is presently 16.15%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 10.93%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 30.13% and 28.10%, respectively.
CADL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -13.59%. However, over the past six months, we’ve seen a weaker performance of 8.07%. The price of CADL leaped by -10.55% over the last 30 days. And in the last five days, it has fallen by -15.73%.
